If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
781.00    -21.00 (-2.62%)
Bid:
778.50
Ask:
781.50
Spread: 3.00 (0.385%)
Market Cap: £900.45m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Year-end Trading Update

14 Apr 2025 07:00

RNS Number : 7947E
Kainos Group plc
14 April 2025
 

14 April 2025

Kainos Group plc

("Kainos" or the "Company") 

 

Year-end Trading Update

 

Kainos Group plc (KNOS), a UK-headquartered IT provider with expertise across three divisions, Digital Services, Workday Services, and Workday Products, today issues a trading update for the year ended 31 March 2025.

 

Following a solid Q4 performance, underpinned by a disciplined approach to costs, the Board expects to deliver revenues and adjusted PBT in line with consensus forecasts*.

 

· Overall, our business improved in the final quarter of the financial year, recording low-single-digit percentage growth. We believe that given the volatile macro-economic environment, we have maintained an appropriate balance between growth, international expansion, investment for the future and profitability.

 

· Once again, our Workday Products division delivered a very strong financial performance, achieving Annual Recurring Revenue (ARR) in excess of £72m at period end. Our Built on Workday partnership continues to progress well and positions Kainos strongly to meet our initial ARR goal of £100 million by 2026 and advance toward our ambitious target of £200m ARR by 2030.

 

· In Digital Services, following the election-related hiatus, our public sector revenues returned to growth in H2 and our team continues to work hard to position Kainos to benefit from the UK Government's commitment to improving public services through digital transformation. Our healthcare revenues continued to grow strongly, and we recorded very strong growth in our international-related revenues. Within commercial sector, activity remained well below prior-year levels.

 

· As previously noted, demand in our Workday Services division has remained subdued, leading to further reductions in H2. As market-related pressures have started to moderate, we are cautiously encouraged by signs of recovery and increasing activity across our international customer base, including recent wins in Australia and New Zealand.

 

Kainos continues to operate in markets where there are clear long-term structural drivers, including the emerging opportunities presented by the wider adoption of AI. We remain confident in our strategy to deliver against these opportunities.

 

Our long-term customer relationships and the commitment of our people continue to drive valuable outcomes. As always, we are grateful for the trust our customers place in us and the support and resilience of our colleagues - particularly in the wake of the recent restructuring, which saw 190 people leave Kainos as part of the organisational changes.

 

We continue to be supported by a robust backlog and pipeline, along with a strong balance sheet and a disciplined approach to capital allocation. Combined with healthy cash flow, these provide a solid foundation as we focus on driving long-term value for shareholders.

 

Our results for the full year ended 31 March 2025 will be announced on 19 May 2025.

 

* Note: Company compiled range is based on known sell side analyst estimates that have been updated since 01 November 2024. The ranges are: Revenue £363.3m - £366.8m and Adjusted PBT £64.1m - £68.2m. The respective consensus figures are £365.6m and £65.4m.

 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths / Nick Prowting

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

 

About Kainos

Kainos Group plc is a UK-headquartered provider of sophisticated IT services to major public sector, commercial and healthcare customers. Our expertise spans three divisions: Digital Services, Workday Services, and Workday Products.

 

Digital Services: We develop and support custom digital service platforms that transform service delivery in public, commercial, and healthcare sectors. Our solutions ensure security, accessibility, cost-effectiveness, and improved user outcomes.

 

Workday Services: Specialising in deploying Workday, Inc.'s Finance, HR, and Planning products, we are a respected partner in Europe and North America. Experienced in complex deployments, we are trusted to launch, test, expand, and support Workday systems.

 

Workday Products: Our established product suite, incorporating Smart Test, Smart Audit, and Smart Shield, complements Workday by enhancing system security and compliance. Our Employee Document Management product, launched in October 2023, improves document generation and storage within Workday while supporting global compliance requirements. Over 450 global customers use one or more of our products.

 

Our people are central to our success. We have more than 2,800 people in 20 countries across Europe, Asia, and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIJMLTMTBBMTA
Date   Source Headline
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.